@profleandro182's low-T treatment claims, fact-checked
Quick answer
HCG, clomiphene, and testosterone replacement are three approaches for treating male hypogonadism. HCG and clomiphene preserve natural hormone production and fertility, while TRT provides more reliable symptom relief but suppresses the hypothalamic-pituitary-testicular axis.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Prof Leandro claims HCG doesn't increase circulating testosterone but preserves testicular function and fertility. He positions clomiphene as a stimulator of the hypothalamic-pituitary axis to boost natural testosterone production, recommending 25mg daily or every other day, possibly 50mg in select cases.
The video attempts to differentiate between three common low testosterone treatments: HCG, clomiphene citrate, and traditional testosterone replacement therapy. The creator presents himself as explaining the "important difference" between these options for men with hypogonadism.
Is the HCG claim accurate?
This is where things get messy. Coviello et al. (JCEM, 2005) found that HCG at 500 IU every other day increased serum testosterone from 175 ng/dL to 400 ng/dL in hypogonadal men. That's definitely an increase in circulating testosterone.
The HAARLEM study (Smit et al., JCEM, 2021) showed HCG monotherapy raised total testosterone levels while maintaining intratesticular testosterone and sperm production. So HCG does both things: it increases circulating testosterone AND preserves fertility.
Prof Leandro got this backwards. HCG absolutely increases circulating testosterone levels while preserving testicular function.
What about the clomiphene dosing recommendations?
The clomiphene dosing advice is more reasonable. Guay et al. (International Journal of Impotence Research, 2003) used 25mg daily and found testosterone increased from 248 ng/dL to 610 ng/dL in older men with low-T.
The larger study by Katz et al. (BJU International, 2012) used 25mg daily in 125 men and saw testosterone rise from 248 ng/dL to 442 ng/dL after three months. Some men did need dose increases to 50mg daily for optimal response.
So the 25mg starting dose recommendation matches published protocols. The mechanism explanation is also correct: clomiphene blocks estrogen receptors in the hypothalamus, increasing LH and FSH release.
How do these actually compare to standard TRT?
Here's what the video misses entirely. Snyder et al. (NEJM, 2016) in the TTrials found testosterone gel increased levels from 234 ng/dL to 498 ng/dL with significant improvements in sexual function and mood.
Both HCG and clomiphene preserve the hypothalamic-pituitary-testicular axis, while exogenous testosterone shuts it down. But they're not equivalent in effectiveness.
Clomiphene works in about 60-70% of men based on multiple studies. HCG works more consistently but requires injections. Traditional TRT is most reliable for symptom improvement but kills fertility and natural production.
What should you actually know about these options?
If you're trying to preserve fertility while treating low testosterone, both HCG and clomiphene are reasonable first-line options. The American Urological Association guidelines support this approach for men wanting to maintain reproductive potential.
HCG mimics LH directly at the testes, while clomiphene works upstream at the brain level. Both can increase testosterone levels, contrary to what this video claims about HCG.
The choice between them often comes down to practical factors: clomiphene is oral but doesn't work for everyone, while HCG requires injections but tends to be more reliable. Neither option guarantees you'll reach optimal testosterone levels, which is why some men eventually need traditional TRT.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @profleandro182's low-T treatment claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
@profleandro182's low-T treatment claims, fact-checked should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
Compare available products and select the relevant treatment page for its specific next step.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
HCG, clomiphene, and testosterone replacement are three approaches for treating male hypogonadism.
FormBlends verdict
HCG, clomiphene, and testosterone replacement are three approaches for treating male hypogonadism. HCG and clomiphene preserve natural hormone production and fertility, while TRT provides more reliable symptom relief but suppresses the hypothalamic-pituitary-testicular axis.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- HCG, clomiphene, and testosterone replacement are three approaches for treating male hypogonadism. HCG and clomiphene preserve natural hormone production and fertility, while TRT provides more reliable symptom relief but suppresses the hypothalamic-pituitary-testicular axis.
- HCG does increase circulating testosterone levels while preserving fertility, contrary to the video's main claim
- Clomiphene at 25mg daily increased testosterone from 248 ng/dL to 442 ng/dL in the Katz study of 125 men
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- HCG does increase circulating testosterone levels while preserving fertility, contrary to the video's main claim
- Clomiphene at 25mg daily increased testosterone from 248 ng/dL to 442 ng/dL in the Katz study of 125 men
- Both HCG and clomiphene preserve natural hormone production, unlike traditional testosterone replacement therapy
- Clomiphene works effectively in about 60-70% of men with hypogonadism based on clinical studies
- The choice between these fertility-preserving options often depends on injection tolerance and individual response rates
- Traditional TRT remains more reliable for symptom improvement but permanently suppresses natural testosterone production
- American Urological Association guidelines support HCG and clomiphene as first-line treatments for men wanting to preserve fertility
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Prof Me Leandro Moscardi · TikTok creator
16.4K views on this video
Respondendo a @desce mais um post HCG vs Clomifeno vs TRT: Entenda a Diferença no Tratamento de Testosterona Baixa Falamos sobre a diferença crucial entre HCG, Clomifeno e TRT no tratamento de testos
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Prof Me Leandro Moscardi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.